Back to search

University of Ioannina

Απόπτωση, οξειδωτικό στρες και καρδιαγγειακή νόσος σε ασθενείς με χρόνια νεφρική νόσο

Abstract

dc:description

Introduction: Chronic kidney disease (CKD) constitutes a huge epidemiological problem in the world and the annual incidence of patients ending to dialysis has been increasing by 5-8 %. It is estimated that the number of haemodialysis (HD) patients in the world from 1.1 million in 2001 will increase to 2 million in 2010 and the global cost will exceed 1 trillion USD in 2010. The proportion of patients in the general population of USA with CKD stages 1-5 accounts to nearly 11%, which is 60-times more compared to the number of patients starting HD, indicating that a large number of patients with CKD in the general population is asymptomatic, while a large number of these patients will die from cardiovascular disease before receiving renal replacement therapy. Once CKD is established sooner or later it is expected to progress to end-stage renal failure and dialysis. However, despite the significance of the above arguments there is luck of large longitudinal studies on the natural history of CKD progression and effectively it is unknown how many and when patients with CKD will end up to dialysis. It is apparent, therefore, that there is urgent need for well-designed prospective studies in order to define the rate of CKD progression and pathophysiological disturbances, mainly related to cardiovascular function, that are associated with this progression. In Greece there is complete lack of information about the number of patients with variable stages of CKD in the general population. Furthermore, there is not any information at all on the incidence of risk factors that are related to the progression of cardiovascular injury. Besides the conventional risk factors that were described by the Framingham Study, it is known that other factors related to uraemia may contribute to the pathophysiological alterations of the cardiorenal damage. Among the latter factors oxidative stress (OS), apoptosis and inflammation play a pivotal role in this process. The aim of this thesis was to study the incidence of CKD stages 1-4 and define associated echocardiovascular findings in a selected population of outpatients in two departments of nephrology and relate risk factors with the progression of both renal and cardiac injury. Patients-Methods: Two hundred and ninety nine adult patients were studied from the outpatient clinics of two hospitals (University Hospital of Ioannina and General Hospital of Veria). There were 119 men (52%) and 110 women (48%) and their mean age was 64.8 years. The main primary renal diseases were hypertensive nephrosclerosis (15%), diabetic nephropathy (14%) and interstitial nephropathy (11%), while in 35% of the patients the primary cause was unknown. At recruitment all patients were screened for demographic, anthropometric and clinical parameters and full haematological and biochemistry tests were carried out. For the classification into CKD stages 1-4 the MDRD equation was used and the distribution of the patients was: 24 (10.5%), 58 (25.3%), 85 (37.1%), 62 (27.1%) in the respective CKD stages 1-4. Also at recruitment specific parameters of apoptosis, OS, inflammation and endothelial dysfunction were carried out. Namely, apoptotic activity was measured by the expression of Bcl-2 and Annexin V-PI in peripheral mononuclear cells and the serum levels of Fas, FasL, and TNF-a, while oxidative stress activity was reflected by measuring serum levels of 8-epiPGF2a, oxidized LDL (ox-LDL), carbonyls and total antioxidant status (TAS). Chronic inflammation and endothelial dysfunction were assessed by estimation of serum CRP, ICAM-1, VCAM-1, IL-6 and plasma fibrinogen. Echocardiographic examination was carried out in all patients within one month from recruitment including measurement of RWT, IVSTd, PWTd, LVDd, LVDs, LVmass and LVMI. Also estimations of fraction shortening (FS) and ejection fraction (EF) were available, while diastolic dysfunction was estimated by measuring diastolic fill of the LV and recording the maximal velocity of the first diastolic fill (E) and the following maximal velocity of the atrial fill (A) in order to calculate the ratio E/A. Statistical analysis was carried out by the SPSS 11. Comparison of mean values of different parameters in the CKD stages 1-4 were carried out using analysis of variance (ANOVA), while correlation between two continuous variables was done using the non-parametric Spearman correlation. Stepwise multiple regression analysis was also applied in order to discriminate the most significant cofounders interfering between the association of eGFR and echocardiographic findings, and the specific markers of apoptosis, OS and inflammation. Results: IVSTd, PWTd, RWT, LVmass and LVMI increased significantly for CKD stage 1 to 4, (IVSTd: 0.95±0.2 to 1.2±0.3 p<0.001, PWTd: 0.8±0.1 to 1±0.25 p<0.001, RWTd: 0.33±0.06 σε 0.43±0.1 p<0.001, LVmass: 216±95 σε 305±102 p<0.001, LVMI: 111±39 σε 167±52 p<0.001), and all these parameters correlated significantly with eGFR (p<0.001). Stepwise multiple regression showed that age, plasma fibrinogen and serum levels of VCAM-1 and Fas affected the correlation between eGFR and echo findings but did not reverse the significance. With regards to cardiac geometry only 37 of 206 patients (18%) had normal echo findings, 9 patients (4.5%) had concentric remodelling and 57 patients (28%) had concentric hypertrophy, while eccentric hypertrophy was observed in 50% of the patients. Diastolic function was normal in 85% of patients, while 15% (31 patients) had abnormal E/A fraction. Finally, 5 of the 217 patients (2.3%) had EF<50%, indicating LV systolic dysfunction and all these patients were suffering from ischemic heart disease. These findings suggest that cardiac remodelling takes place early during the progression of CKD and abnormalities of cardiac geometry may be found in a large proportion of patients with early stages of CKD. Expression of Bcl-2 was found to reduce significantly in peripheral blood monocytes as CKD was progressing (p<0.002 and 0.001 respectively), indicating that anti-apoptotic activity was declining. In contrast, the activity of the proapoptotic molecule Fas increased significantly from stage CKD1 to 4 and the same was observed with serum levels of TNF-a. The percentages of lymphocytes and monocytes binding to Annexin V-PI and serum levels of Fas ligand did not differ between CKD stages 1-4. Stepwise multiple regression showed that the strong correlation between eGFR and serum Fas was not affected by any of the clinical variables, while BMI had some effect in the association between eGFR and TNF-a (p=0.001). Serum VCAM-1 also had some effect both in the association between eGFR and serum Fas, and eGFR and serum TNF-a implicating the interrelation between apoptotic and pro-nflammatory markers. With regards to oxidative stress markers only serum levels of 8-epiPGF2a increased significantly with the progression of CKD stages (p<0.001). Stepwise multiple regression showed that the association between eGFR and levels of 8-epiPGF2a was influenced by age (p<0.001) and BMI (p=0.001). From the laboratory variables Hb, serum albumin, serum VCAM-1 and Fas were also found to affect the association of the two variables, suggesting the interplay between traditional risk factors (age, BMI) and non-traditional factors (anaemia, malnutrition, inflammation) in the pathophysiologic alterations during the early stages of CKD. The pro-inflammatory markers VCAM-1, IL-6 and fibrinogen showed a significant negative correlation with eGFR (p<0.001, p=0.013 and p<0.001 respectively). In contrast no correlation was found between levels of CRP, ICAM1 and eGFR. Stepwise multiple regression showed that the association between eGFR and VCAM-1 was independent of the effect of any clinical variable, while Fas had some effect (p=0.003). Finally, the association between eGFR and fibrinogen was affected by serum albumin, serum Fas, LVMI and blood pressure (p<0.001, p=0.002, p=0.005 and p<0.05 respectively). With regards to the relation between LVMI, as most representative of the echocardiographic parameters, and the markers of apoptosis, OS and inflammation it was found that LVMI correlated significantly with the proapoptotic molecule Fas, serum TNF-a, serum 8-epiPGF2a, serum VCAM-1, IL-6 and plasma fibrinogen (p<0.001, p=0.01, p=0.03, p<0.001, p=0.005 and p<0.001 respectively). Interrelations between markers of apoptosis, OS and inflammation showed that there was a number of variable significant correlations between Bcl-2 vs. Fas, carbonyls, TNF-a, fibrinogen (negative). Serum soluble Fas levels correlated positively with VCAM-1, IL-6 and fibrinogen and FasL correlated positively with VCAM-1 and negatively with fibrinogen, while TNF-a had a significant positive correlation with serum VCAM-1, ICAM-1, IL-6 and plasma fibrinogen. Furthermore, serum 8-epiPGF2a was found to correlate significantly with serum VCAM-1, ICAM-1 and fibrinogen. Regarding markers of inflammation and endothelial dysfunction serum VCAM-1 levels correlated positively with levels of all other inflammation markers except from CRP, while ICAM-1 levels correlated positively with CRP. Serum IL-6 levels had an absolutely justified positive correlation with CRP and plasma fibrinogen, as IL-6 is mainly responsible for the increased production of these two acute phase proteins. Finally plasma fibrinogen and serum CRP had a significant positive correlation. Conclusions: LVH and abnormalities in cardiac geometry appeared in high percentages in the early stages of CKD and progressed in parallel with the progression of CKD. As renal function declined there was a significant reduction in anti-apoptotic activity and an increased pro-apoptotic and pro-oxidative activity. Furthermore, there was a significant increase of the pro-inflammatory markers, namely VCAM-1, IL-6 and fibrinogen. LVMI was found to correlate significantly with pro-apoptotic (Fas and TNF-a), pro-oxidative (8-epiPGF2a) and pro-inflammatory markers (VCAM-1, IL-6 and plasma fibrinogen). The parameters of apoptosis, OS inflammation and endothelial dysfunction showed a number of variable correlations between each other and between other clinical and laboratory variables suggesting their interplay as common risk factors -traditional and non-traditional- of the parallel progression of the cardiorenal injury. These findings suggest that prompt assessment of patients with CKD is mandatory during the early stages and holistic intervention against risk factors contributing to damage of both organs may prevent the progression of kidney and cardiac disease.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ντουνούση, Ευαγγελία
  • Dounousi, Evangelia

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20222

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ντουνούση, Ευαγγελία; Dounousi, Evangelia. Απόπτωση, οξειδωτικό στρες και καρδιαγγειακή νόσος σε ασθενείς με χρόνια νεφρική νόσο. University of Ioannina, 2008. http://hdl.handle.net/10442/hedi/20222